In this new Pandemic Response series, StartUp Health’s senior writer, Nicole Clark talks with Italy-based Andrea Riposati, CEO of Dante Labs, about how his DNA tests are being used to sequence the whole genome of patients with COVID-19. His aim? To understand what genes play a role in our reaction to the deadly disease.
Want more content like this? You can subscribe to the podcast as well as other health innovation updates at startuphealth.com/content. Sign up for StartUp Health Insider™ to get funding insights, news, and special updates delivered to your inbox.